Inhibitory Effect of Oat Bran Ethanol Extract on Survival and Gemcitabine Resistance of Pancreatic Cancer Cells.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
24 Oct 2019
Historique:
received: 04 09 2019
revised: 16 10 2019
accepted: 21 10 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 13 3 2020
Statut: epublish

Résumé

Pancreatic cancer (PC) is one of the most aggressive malignancies in the world. Gemcitabine (Gem), a nucleoside pyrimidine analogue, is a first-line chemotherapeutic drug for PC, but the tumor response rate of Gem is very low and resistance to Gem has emerged as a major problem in the treatment of PC. Oat bran, used as animal and human food, has been found to be beneficial to health. In this study, effects of oat bran ethanol extract (OBE) on PC cells and Gem-resistant PC cells were investigated in vitro. OBE decreased cell survival and colony forming ability of PC cells, without any cytotoxicity on the normal pancreatic cells. Flow cytometry analysis and TUNEL assay showed that the OBE reduced G1/S phase transition and induced death in PC cells through AMPK activation and downregulation of JNK. Additionally, OBE could overcome Gem resistance through reduction in RRM1/2 expression and showed synergistic effect by combinatorial treatment with Gem on Gem-resistant PC cells. Additionally, LC-MS data showed that avenacoside A was a component of OBE. Thus, this study elucidated the anti-proliferative effect of OBE and synergistic effect of OBE with Gem on PC cells and Gem-resistant cells.

Identifiants

pubmed: 31652886
pii: molecules24213829
doi: 10.3390/molecules24213829
pmc: PMC6866133
pii:
doi:

Substances chimiques

Plant Extracts 0
Deoxycytidine 0W860991D6
Ethanol 3K9958V90M
Gemcitabine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea
ID : NRF-2018R1C1B6002722
Organisme : National Research Foundation of Korea
ID : NRF-2019R1I1A3A01060998
Organisme : Rural Development Administration
ID : Project No. PJ013524012019

Références

Cancer. 1999 Mar 15;85(6):1261-8
pubmed: 10189130
Oncogene. 1999 Dec 20;18(55):7883-99
pubmed: 10630641
Food Chem. 2018 Jan 15;239:260-267
pubmed: 28873568
Genes Dev. 1993 May;7(5):812-21
pubmed: 8491378
Trends Cell Biol. 2013 Dec;23(12):620-33
pubmed: 23958396
Trends Immunol. 2006 May;27(5):244-50
pubmed: 16584921
J Agric Food Chem. 2016 Feb 24;64(7):1549-56
pubmed: 26852819
Chin J Cancer. 2012 Oct;31(10):476-83
pubmed: 22692073
Int J Oncol. 2011 Aug;39(2):473-82
pubmed: 21617862
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cell Cycle. 2002 Mar-Apr;1(2):122-3
pubmed: 12429920
J Oleo Sci. 2015;64(9):915-32
pubmed: 26250424
Mol Cancer Ther. 2002 Jun;1(8):639-49
pubmed: 12479224
Front Biosci (Landmark Ed). 2014 Jan 01;19:447-74
pubmed: 24389195
N Engl J Med. 2014 Sep 11;371(11):1039-49
pubmed: 25207767
Nutr Res. 2018 Jun;54:80-92
pubmed: 29914670
Biochem Biophys Res Commun. 2018 May 27;500(1):26-34
pubmed: 28676391
J Biol Chem. 1999 Jul 23;274(30):21155-61
pubmed: 10409669
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Br J Nutr. 1998 Aug;80 Suppl 1:S147-71
pubmed: 9849357
Cell. 1994 Jul 15;78(1):67-74
pubmed: 8033213
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Int J Biol Macromol. 2015 Jan;72:757-63
pubmed: 25285849
J Agric Food Chem. 2000 Jun;48(6):2008-16
pubmed: 10888490
Oncotarget. 2017 Jun 6;8(23):38022-38043
pubmed: 28410237
Int J Mol Sci. 2018 Jun 06;19(6):
pubmed: 29882812
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Adv Enzyme Regul. 1984;22:27-55
pubmed: 6382953
PLoS One. 2008;3(11):e3695
pubmed: 19002265
Zhongguo Fei Ai Za Zhi. 2011 May;14(5):421-8
pubmed: 21569648
Biochem Biophys Res Commun. 1997 Jan 23;230(3):481-8
pubmed: 9015345
Cancer Res. 2002 Jun 1;62(11):3257-63
pubmed: 12036942
Planta Med. 2011 Jun;77(9):900-6
pubmed: 21240840
J Clin Oncol. 1997 Jun;15(6):2403-13
pubmed: 9196156
Eur Surg Res. 2012;48(3):111-20
pubmed: 22538523
Nature. 1980 Feb 7;283(5747):593-6
pubmed: 6243744
Oncogene. 2015 Apr 16;34(16):2011-21
pubmed: 24909171
N Engl J Med. 2013 Oct 31;369(18):1691-703
pubmed: 24131140

Auteurs

Myoungjae Kim (M)

Department of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk 54538, Korea. myoung194@naver.com.

Jeong-Geon Mun (JG)

Department of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk 54538, Korea. wjdrjs92@daum.net.

Hyun Jin Lee (HJ)

National Institute of Crop Science, Rural Development Administration, Crop Foundation Research Division, 181 Hyeoksinro, Isomyeon, Wanjugun, Jeonbuk 55365, Korea. poi7346@rda.go.kr.

So-Ri Son (SR)

Department of Biomedical Science and Technology, Graduate School, Kyung Hee University, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea. allosori@khu.ac.kr.

Mi-Ja Lee (MJ)

National Institute of Crop Science, Rural Development Administration, Crop Foundation Research Division, 181 Hyeoksinro, Isomyeon, Wanjugun, Jeonbuk 55365, Korea. esilvia@korea.kr.

Ji-Ye Kee (JY)

Department of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, 460 Iksandae-ro, Iksan, Jeonbuk 54538, Korea. keejy@wku.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH